Panretin (alitretinoin topical gel – Eisai) — Cigna

Initial criteria

• Patient is not receiving systemic therapy for Kaposi sarcoma; AND
• The medication is prescribed by or in consultation with a dermatologist, oncologist, or infectious disease specialist.

Approval duration

1 year